Today: 19 January 2026
Subscribe

Nebius stock slips today after CEO files to sell shares — what traders are watching next

Nebius stock slips today after CEO files to sell shares — what traders are watching next

NEW YORK, December 30, 2025, 15:09 ET — Regular session Nebius Group N.V. shares slipped on Tuesday after a regulatory filing showed chief executive Arkady Volozh plans to sell a small block of stock around year-end. SEC The disclosure matters because Nebius has become a closely watched AI infrastructure name, where investors have been quick to react to any potential…
30 December 2025
··
Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

NEW YORK, December 30, 2025, 3:07 PM ET — Regular session Shares of Almonty Industries Inc fell about 3.9% to $8.90 in afternoon trading on Tuesday after giving up an early rise, with the stock swinging between $8.90 and $9.39. The pullback comes as investors focus on tungsten, a hard metal used in munitions, industrial tooling and electronics, at a…
30 December 2025
···
SoFi stock today: SOFI barely moves after Fed minutes; what investors watch next

SoFi stock today: SOFI barely moves after Fed minutes; what investors watch next

NEW YORK, December 30, 2025, 3:01 PM ET — Regular session SoFi Technologies, Inc. shares were down 0.1% at $26.80 on Tuesday afternoon, after trading between $26.65 and $27.14. The Federal Reserve released minutes from its Dec. 9–10 meeting at 2:00 p.m. ET, putting fresh attention on how quickly policymakers might cut interest rates again. Federal Reserve That matters for…
30 December 2025
···
Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

NEW YORK, December 30, 2025, 14:54 ET — Regular session Shares of Praxis Precision Medicines Inc (NASDAQ: PRAX) slipped about 3% on Tuesday, giving back part of a sharp rally sparked by an FDA regulatory boost for its lead essential tremor program. The stock was down 3% at $295.50 as of 2:39 p.m. ET, after opening at $304.00 and trading…
30 December 2025
····
Why Western Digital stock is down today: WDC slides as year-end rotation cools AI-hardware trades

Why Western Digital stock is down today: WDC slides as year-end rotation cools AI-hardware trades

NEW YORK, December 30, 2025, 3:00 PM ET — Regular session Western Digital Corp shares fell 1.7% to $176.55 on Tuesday, after opening higher and sliding through the afternoon. The stock touched $181.34 earlier in the session before dipping as low as $176.31. The pullback lands after a standout year for the data-storage maker, whose shares have surged about 303%…
30 December 2025
····
Carvana stock drifts in thin trade after Fed minutes — what CVNA investors are watching

Carvana stock drifts in thin trade after Fed minutes — what CVNA investors are watching

NEW YORK, December 30, 2025, 14:52 ET — Regular session Carvana Co shares edged lower on Tuesday afternoon, trading down less than 0.1% at $433.32, as year-end portfolio shifts kept risk appetite uneven across consumer names. The muted move matters because Carvana has become a high-beta momentum stock after a sharp turnaround, and thin holiday volumes can exaggerate day-to-day swings…
30 December 2025
···
Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

NEW YORK, December 30, 2025, 14:50 ET — Regular session Shares of lululemon athletica inc. fell about 0.6% to $211.30 in afternoon trading on Tuesday after founder Chip Wilson launched a proxy fight — a campaign to win shareholder votes for board seats — seeking to reshape the board. The stock had gained about 2% on Monday, Reuters reported. Reuters…
30 December 2025
····
Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

NEW YORK, December 30, 2025, 14:40 ET — Regular session Shares of Cogent Biosciences, Inc. fell 2.7% to $36.88 on Tuesday after the biotech said it submitted a New Drug Application to the U.S. Food and Drug Administration for its drug candidate bezuclastinib in nonadvanced systemic mastocytosis. Yahoo Finance An NDA is the formal request asking the FDA to review…
30 December 2025
····
Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch

Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch

NEW YORK, December 30, 2025, 2:56 PM ET — Regular session Amgen Inc. shares were down 0.4% at $328.32 at 2:56 p.m. ET on Tuesday, after trading between $325.90 and $330.18. The modest move matters because investors are grading Amgen’s pipeline for new growth while several mature products face price pressure and biosimilar competition. Oncology and obesity remain two key…
30 December 2025
····
Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land

Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land

NEW YORK, December 30, 2025, 14:44 ET — Regular session Texas Instruments Incorporated (TXN) shares were little changed on Tuesday after memory developer Weebit Nano said it had licensed its resistive random access memory, or ReRAM, technology to the chipmaker. The stock was down about 0.01% at $175.67 in afternoon trade, and TI executive Amichai Ron said the partnership would…
30 December 2025
····
Mastercard stock dips in thin year-end trade as Fed minutes sharpen rate focus

Mastercard stock dips in thin year-end trade as Fed minutes sharpen rate focus

NEW YORK, December 30, 2025, 14:45 ET — Regular session Mastercard Incorporated shares were down 0.3% at $576.37 in afternoon trading on Tuesday, after moving between $574.55 and $579.49 earlier in the session. Volume was about 683,000 shares. The small move still matters into year-end because investors use card networks as a bellwether for consumer spending. Mastercard earns fees when…
30 December 2025
····
1 … 557 558 559 560 561 … 2,187

Stock Market Today

  • Alibaba-Backed Moonshot AI Valued at $4.8 Billion Amid Chinese AI IPO Boom
    January 19, 2026, 9:26 AM EST. Alibaba-backed startup Moonshot AI has seen its valuation rise by $500 million to $4.8 billion in a new funding round, according to sources familiar with the deal. This jump follows IPO successes of Chinese AI rivals Zhipu and MiniMax in Hong Kong, which have attracted significant investor interest. Moonshot AI, known for its Kimi chatbot popular in China, is benefiting from strong demand amid restricted access to U.S. AI services in mainland China. Previous investors include IDG, Alibaba, and Tencent. Despite growing speculation, Moonshot AI has not announced any plans for an initial public offering (IPO). The surge highlights China's expanding AI market in contrast to U.S.-China regulatory tensions impacting technology firms.
Go toTop